Free Trial

ImmunoPrecise Antibodies (IPA) SEC Filings & 10K Form

ImmunoPrecise Antibodies logo
$1.34 +0.28 (+25.94%)
Closing price 03:58 PM Eastern
Extended Trading
$1.34 0.00 (0.00%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ImmunoPrecise Antibodies SEC Filings

DateFilerForm TypeView
06/24/2025
7:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2025
7:25 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2025
7:11 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
7:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
8:55 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
12:43 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
6:45 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2025
10:17 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2025
9:48 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
8:43 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
7:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
8:54 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
11:29 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
9:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
12:58 PM
Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
Form SCHEDULE 13G/A
01/22/2025
9:30 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
10:30 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2025
9:20 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
8:03 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
7:36 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
7:37 AM
ImmunoPrecise Antibodies (Filer)
Form 20-F/A
12/10/2024
7:33 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
7:33 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
8:17 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:54 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
6:36 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
8:08 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
2:25 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
8:39 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
7:02 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
8:13 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
1:40 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
8:04 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
8:03 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
8:41 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:01 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
8:21 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/18/2024
11:15 PM
ImmunoPrecise Antibodies (Filer)
Form EFFECT
08/06/2024
4:16 PM
ImmunoPrecise Antibodies (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
07/30/2024
12:57 PM
ImmunoPrecise Antibodies (Filer)
Form D
Notice of Exempt Offering of Securities 
07/29/2024
7:35 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Banks aren’t ready for this altcoin—are you? (Ad)

Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…

Discover our #1 crypto for the market right now.
07/29/2024
7:38 AM
ImmunoPrecise Antibodies (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/23/2024
8:55 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
8:41 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
7:32 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IPA) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners